Is there a limited value of cytoreductive surgery in elderly patients with malignant gliomas?

BACKGROUND: Glioblastoma (GB) is well known for being the most aggressive primary cerebral malignancy. The peak incidence is at 60–70 years of age, with over half of patients aged over 65 years at diagnosis. METHODS: Patients with a confirmed histological diagnosis of GB between January 2009 and Jun...

Descripción completa

Detalles Bibliográficos
Autores principales: Elserius, Anne S. L., Hodson, James, Zisakis, Athanasios, Ughratdar, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345099/
https://www.ncbi.nlm.nih.gov/pubmed/35928314
http://dx.doi.org/10.25259/SNI_438_2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345099/
https://www.ncbi.nlm.nih.gov/pubmed/35928314
http://dx.doi.org/10.25259/SNI_438_2022

Ejemplares similares